Galectin Therapeutics Inc
GALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133416
In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Galectin Therapeutics Inc changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 55 | 60 | +5 |
| Shares | 7.33M | 7.47M | +142.9K (+2.0%) |
| Value | $15.2M | $12.0M | −$3.13M (−20.7%) |
New holders (9)
Institutions that held Galectin Therapeutics Inc at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Atria Wealth Solutions, Inc. | 285,700 | $460.0K | 0.01% |
| Summit Trail Advisors, LLC | 23,855 | $38.0K | 0.00% |
| Centaurus Financial, Inc. | 21,114 | $34.0K | 0.00% |
| Wolverine Trading, LLC | 16,359 | $28.0K | 0.00% |
| Stock Yards Bank & Trust Co | 10,500 | $17.0K | 0.00% |
| Howard Capital Management Inc. | 10,000 | $16.0K | 0.00% |
| Meeder Asset Management Inc | 7,994 | $13.0K | 0.00% |
| Money Concepts Capital Corp | 1,000 | $2.00K | 0.00% |
| Global Retirement Partners, LLC | 350 | $0 | 0.00% |
Sold out (4)
Institutions that held Galectin Therapeutics Inc at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Citadel Advisors LLC | 43,382 | $90.0K |
| Jump Financial, LLC | 23,200 | $48.0K |
| Squarepoint Ops LLC | 13,182 | $27.0K |
| CoreCap Advisors, LLC | 9,195 | $19.0K |